Drug Targets in Kinetoplastid Parasites
If viewed globally, the parasitic diseases pose an increasing threat to human health and welfare. The diseases caused by kinetoplastid protozoan parasites like Leishmania and Trypanosoma continue as a cause of suffering for many millions of people in both tropical and subtropical regions of the worl...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Language: | English |
| Published: |
New York, NY :
Springer New York : Imprint: Springer,
2008.
|
| Edition: | 1st ed. 2008. |
| Series: | Advances in Experimental Medicine and Biology,
625 |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-0-387-77570-8 |
Table of Contents:
- Arsenite Resistance in Leishmania and Possible Drug Targets
- Unique Characteristics of the Kinetoplast DNA Replication Machinery Provide Potential Drug Targets in Trypanosomatids
- Drugs and Transporters in Kinetoplastid Protozoa
- Selective Lead Compounds against Kinetoplastid Tubulin
- Fishing for Anti-Leishmania Drugs: Principles and Problems
- Sterol 14-Demethylase Inhibitors for Trypanosoma cruzi Infections
- Histone Deacetylases
- Targeting Glycoproteins or Glycolipids and Their Metabolic Pathways for Antiparasite Therapy
- DNA Topoisomerases of Leishmania: The Potential Targets for Anti-Leishmanial Therapy
- Antiparasitic Chemotherapy:
- Searching the Tritryp Genomes for Drug Targets
- Purine and Pyrimidine Metabolism in Leishmania.